Vutrisiran is associated with preservation of intrinsic capacity and healthy ageing in patients with transthyretin amyloidosis with cardiomyopathy: post hoc analysis of HELIOS-B

Vyndaqel (tafamidis meglumine) - Pfizer

Amvuttra (vutrisiran) - Alnylam

O Lairez1; H Malerbi1; MS Maurer2; P de Souto Barreto3; C Fumagalli4; T Damy5; R Pfister6; Y Izumiya7; W Moody8; A Bakdache9; H Zheng10; B Vellas3

May 11, 2026